文献速递分子诊断临床微生物临床免疫

液滴数字PCR诊断血液恶性肿瘤患者侵袭性曲霉病的前瞻性队列研究

Droplet digital PCR for diagnosing invasive aspergillosis in hematological malignancies: a prospective cohort study.
PubMed 文献 · J Clin Microbiol · 2026-10-27

该前瞻性单中心研究纳入203例接受支气管镜检查的血液恶性肿瘤成人患者,评估呼出气冷凝液(EBC)和支气管肺泡灌洗液(BALF)中曲霉液滴数字PCR(ddPCR)诊断侵袭性曲霉病(IA)的准确性。EBC ddPCR性能差(AUC-ROC 0.55),BALF上清ddPCR最佳(AUC-ROC 0.88),敏感性0.65、特异性0.96,优于qPCR且未用抗霉菌药物者AUC达0.95。

要点

  • BALF上清是曲霉ddPCR的最佳标本类型,EBC性能差。
  • BALF上清ddPCR敏感性0.65、特异性0.96,优于qPCR。
  • 未 prior 抗霉菌治疗者BALF上清ddPCR的AUC-ROC达0.95。

核心结论

  • EBC ddPCR对IA诊断价值有限,BALF上清为最佳标本且ddPCR优于qPCR。
  • 未 prior 抗霉菌药物暴露者BALF上清ddPCR诊断性能显著提高。

研究设计与样本

  • 共203例参与者,26例(12.8%)诊断为 probable 或 proven IA,参照EORTC/MSGERC标准且未将PCR纳入参考标准。
  • EBC与BALF同步采集,ddPCR检测EBC及BALF(上清和细胞沉淀),qPCR检测BALF。

主要发现

  • EBC ddPCR的AUC-ROC为0.55(95% CI 0.43-0.67)。
  • BALF上清ddPCR的AUC-ROC为0.88(95% CI 0.80-0.96),敏感性0.65(95% CI 0.43-0.84),特异性0.96(95% CI 0.92-0.99)。
  • BALF上清在ddPCR和qPCR中均优于细胞沉淀检测。
  • 与qPCR相比,ddPCR敏感性更高且特异性相似。
  • 未 prior 抗霉菌治疗者BALF上清ddPCR的AUC-ROC为0.95(95% CI 0.89-1.00)。

关键数值与推荐

  • IA分类采用EORTC/MSGERC标准,未将PCR纳入参考标准。
  • BALF上清ddPCR敏感性0.65(95% CI 0.43-0.84)、特异性0.96(95% CI 0.92-0.99)。
  • EBC ddPCR的AUC-ROC 0.55(95% CI 0.43-0.67)。

临床怎么用

  • BALF上清可作为曲霉ddPCR的首选标本类型,EBC不推荐用于IA诊断。
  • 在未 prior 使用抗霉菌药物的患者中,BALF上清ddPCR诊断准确性更高。

局限性

  • 单中心研究,结果外推需谨慎。
  • IA病例数较少(26例),部分性能估计置信区间较宽。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Our objective was to evaluate the diagnostic accuracy of Aspergillus droplet digital PCR (ddPCR) in exhaled breath condensate (EBC) and bronchoalveolar lavage fluid (BALF) for diagnosing invasive aspergillosis (IA), and to compare its performance with quantitative real-time PCR (qPCR) in patients with hematologic malignancies. We conducted a prospective single-center study, including adults admitted to leukemia and allogeneic hematopoietic stem cell transplant units who underwent bronchoscopy for pulmonary infiltrates between October 2021 and December 2024. EBC and BALF were collected concurrently. ddPCR was performed on EBC and BALF (supernatant and cell pellet); qPCR was performed on BALF samples. IA was classified according to EORTC/MSGERC criteria without incorporating PCR into the reference standard. Diagnostic performance characteristics, including area under the receiver operating characteristic curve (AUC-ROC), were calculated. Among 203 participants, 26 (12.8%) were diagnosed with probable or proven IA. EBC ddPCR showed poor performance (AUC-ROC 0.55, 95% CI 0.43-0.67). BALF supernatant ddPCR demonstrated the best performance (AUC-ROC 0.88, 95% CI 0.80-0.96), with sensitivity of 0.65 (95% CI 0.43-0.84) and specificity of 0.96 (95% CI 0.92-0.99). BALF supernatant outperformed BALF cell pellet testing for both ddPCR and qPCR. Compared with qPCR, ddPCR showed higher sensitivity and similarly high specificity. Among participants without prior mold-active antifungal therapy, BALF supernatant ddPCR showed improved performance (AUC-ROC 0.95, 95% CI 0.89-1.00). In this large prospective study, EBC ddPCR demonstrated limited utility for the diagnosis of IA. BALF supernatant was the optimal specimen type, and ddPCR outperformed qPCR. Diagnostic performance improved substantially without prior mold-active antifungal exposure.IMPORTANCEInvasive aspergillosis is difficult to diagnose in patients with hematologic malignancies, and non-invasive diagnostic approaches are needed. In this prospective study of 203 patients, Aspergillus droplet digital PCR performed poorly in exhaled breath condensate (area under the receiver operating characteristic curve 0.55; 95% CI 0.43-0.67) but showed good diagnostic performance in bronchoalveolar lavage supernatant fluid (area under the receiver operating characteristic curve 0.88; 95% CI 0.80-0.96). Droplet digital PCR demonstrated higher sensitivity than quantitative PCR with similarly high specificity, and bronchoalveolar lavage supernatant fluid consistently outperformed cell pellet testing. Among patients without prior mold-active antifungal therapy, the area under the receiver operating characteristic curve was 0.95 (95% CI 0.89-1.00). These findings support bronchoalveolar lavage supernatant fluid as the preferred specimen for Aspergillus droplet digital PCR and warrant further evaluation of this approach for diagnosing invasive aspergillosis.

来源:J Clin Microbiol,查看原文。版权归原作者所有。

引用

  1. Bitterman, Ng, Arora, et al. Droplet digital PCR for diagnosing invasive aspergillosis in hematological malignancies: a prospective cohort study. J Clin Microbiol. 2026. PMID: 42937364. doi:10.1128/jcm.01140-26

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。